The global demand for Personalized Cancer Medicine Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.
Personalized cancer medicine, also known as precision oncology or precision cancer medicine, is an approach to cancer treatment that uses specific information about a patient's individual tumor characteristics and genetic makeup to tailor the treatment to the unique features of their cancer. This approach aims to optimize treatment efficacy while minimizing side effects and improving patient outcomes.
Advancements in genomic technology, such as next-generation sequencing, have made comprehensive genetic profiling of tumors more accessible and cost-effective, enabling the identification of specific genetic mutations driving cancer growth. This, in turn, has led to the development of targeted therapies tailored to each patient's unique tumor characteristics. Personalized cancer medicine offers better treatment outcomes compared to traditional approaches, as targeted therapies can be more effective in halting tumor growth and improving patient responses and survival rates. The rising cancer incidence and the demand for precision medicine have further fueled the adoption of personalized cancer treatments. Supportive regulatory environments, research investments, patient advocacy, and data-sharing initiatives also contribute to the market's growth. As technology improves and becomes more affordable, personalized cancer medicine is expected to play an increasingly prominent role in oncology, offering individualized and effective treatment options for cancer patients.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized cancer medicine. The growth and trends of personalized cancer medicine industry provide a holistic approach to this study.
This section of the personalized cancer medicine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Application
By End-User
By Biomarker
This section covers the regional outlook, which accentuates current and future demand for the Personalized Cancer Medicine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Personalized Cancer Medicine market include Abbott, Merck, Novartis, Amgen, Celgene, Bayer, Roche, Astellas, Astrazeneca, Johnson & Johnson, Agilent, Takeda. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . PERSONALIZED CANCER MEDICINE – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Type
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-User
3.7.4 Market Attractiveness Analysis By Biomarker
3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL PERSONALIZED CANCER MEDICINE MARKET ANALYSIS BY TYPE
5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Monoclonal Antibodies Historic and Forecast Sales by Regions
5.5 Personalized Cancer Vaccines Historic and Forecast Sales by Regions
5.6 Cancer Cell-targeted Therapies Historic and Forecast Sales by Regions
5.7 Immunotherapies Historic and Forecast Sales by Regions
5.8 Other Historic and Forecast Sales by Regions
6 . GLOBAL PERSONALIZED CANCER MEDICINE MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
...